Search research articles
Contact Us
Filters
Showing results (1-10 of 135) with videos related to
Page
of 14
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
October 7, 2022
Cytotoxicity Models in Chromaffin Cells to Evaluate Neuroprotective Compounds
María F Cano-Abad, Manuela G López
Journal of Pineal Research
|
June 12, 2010
Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells
Alejandro Romero, Javier Egea, Antonio G García, et al.
Biochemical and Biophysical Research Communications
|
August 18, 2010
Mitochondrial Na+/Ca2+ exchanger, a new target for neuroprotection in rat hippocampal slices
Santos M Nicolau, Javier Egea, Manuela G López, et al.
Expert Opinion on Investigational Drugs
|
November 29, 2007
An update on the pharmacology of galantamine
Mercedes Villarroya, Antonio G García, José Marco-Contelles, et al.
Cardiovascular Drug Reviews
|
July 12, 2005
Preclinical profile of PF9404C, a nitric oxide donor with beta receptor blocking properties
Mercedes Villarroya, Manuela G López, Ricardo de Pascual, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
February 23, 2011
Measurement of Ca²+ entry using ⁴⁵Ca²+
Mercedes Villarroya, Manuela G López, María F Cano-Abad, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
January 21, 2006
Measurement of Ca2+ entry using 45Ca2+
Mercedes Villarroya, Manuela G López, María F Cano-Abad, et al.
Journal of Neurochemistry
|
June 2, 2007
Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress
Javier Egea, Angelo O Rosa, Antonio Cuadrado, et al.
European Journal of Medicinal Chemistry
|
October 13, 2006
Synthesis and biological evaluation of new 4H-pyrano[2,3-b]quinoline derivatives that block acetylcholinesterase and cell calcium signals, and cause neuroprotection against calcium overload and free radicals
José Marco-Contelles, Rafael León, Manuela G López, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 8, 2005
Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors
Esperanza Arias, Sonia Gallego-Sandín, Mercedes Villarroya, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 135) with videos related to
Sort By:
Page
of 14
Methods in Molecular Biology (Clifton, N.J.)
|
October 7, 2022
Cytotoxicity Models in Chromaffin Cells to Evaluate Neuroprotective Compounds
María F Cano-Abad, Manuela G López
Journal of Pineal Research
|
June 12, 2010
Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells
Alejandro Romero, Javier Egea, Antonio G García, et al.
Biochemical and Biophysical Research Communications
|
August 18, 2010
Mitochondrial Na+/Ca2+ exchanger, a new target for neuroprotection in rat hippocampal slices
Santos M Nicolau, Javier Egea, Manuela G López, et al.
Expert Opinion on Investigational Drugs
|
November 29, 2007
An update on the pharmacology of galantamine
Mercedes Villarroya, Antonio G García, José Marco-Contelles, et al.
Cardiovascular Drug Reviews
|
July 12, 2005
Preclinical profile of PF9404C, a nitric oxide donor with beta receptor blocking properties
Mercedes Villarroya, Manuela G López, Ricardo de Pascual, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
February 23, 2011
Measurement of Ca²+ entry using ⁴⁵Ca²+
Mercedes Villarroya, Manuela G López, María F Cano-Abad, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
January 21, 2006
Measurement of Ca2+ entry using 45Ca2+
Mercedes Villarroya, Manuela G López, María F Cano-Abad, et al.
Journal of Neurochemistry
|
June 2, 2007
Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress
Javier Egea, Angelo O Rosa, Antonio Cuadrado, et al.
European Journal of Medicinal Chemistry
|
October 13, 2006
Synthesis and biological evaluation of new 4H-pyrano[2,3-b]quinoline derivatives that block acetylcholinesterase and cell calcium signals, and cause neuroprotection against calcium overload and free radicals
José Marco-Contelles, Rafael León, Manuela G López, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 8, 2005
Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors
Esperanza Arias, Sonia Gallego-Sandín, Mercedes Villarroya, et al.
Page
of 14